Skip to main content
Drug Development
Our Pipeline
Evaluation Pipeline
Inaphaea BioLabs
Therapeutic areas
Partnering
Useful Links
News
Investors
Regulatory News
AIM Rule 26
Annual and Half Yearly Reports
Admission Document & Articles
Investments Calculator
Share Alerts
Share Series
Share price look-up
Analyst Research
About us
Board of Directors and Management Team
Scientific Advisory Board
Strategy and Vision
How we work
Working with us
Collaborative Pipeline
Contact us
Search
News
Breadcrumb
News
Category
Articles
Events and presentations
News
Press releases
Videos and audiocasts
News
Meet the ValiRx team: Gerry Desler
12 Sep 2023
News
ValiRx news roundup: August 2023
1 Sep 2023
News
Keynote speakers announced for Inaphaea’s lab launch event
31 Aug 2023
News
Meet the ValiRx Scientific Advisory Board
17 Aug 2023
News
Inaphaea BioLabs and Agility Life Sciences team up
14 Aug 2023
News
Inaphaea BioLabs welcomes Dr Gareth Griffiths
4 Aug 2023
News
Inaphaea BioLabs: the journey to setting up a new laboratory
3 Aug 2023
News
ValiRx news roundup: July 2023
1 Aug 2023
News
Inaphaea BioLabs secures first external contract
19 Jul 2023
News
Meet the Inaphaea BioLabs team: Melissa Barr, Lead Scientist
5 Jul 2023
News
ValiRx news roundup: June 2023
3 Jul 2023
News
Meet the Inaphaea BioLabs team: Dr Dominic Lowen, Senior Scientist
29 Jun 2023
Events and presentations
ValiRx 2023 AGM
29 Jun 2023
News
ValiRx acquires scientific assets from Imagen Therapeutics
16 Jun 2023
Pagination
Current page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Next page
Next
Last page
Last
